Rob Cripe has officially joined the company’s leadership team as Chief Commercial Operations Officer.
Rob joins MicroPort Orthopedics most recently from Integrated Endoscopy where he has served as Chief Commercial Operations Officer since 2016. He brings over thirty years of experience in medical devices, specializing in worldwide commercial execution.
Having held executive responsibilities for sales, marketing, clinical, product development and operations teams with companies such as Zimmer/Biomet, Smith & Nephew and DJO Global, Rob has a deep understanding of successful execution strategies in multi-billion dollar, public organizations. He has also held executive roles for smaller, privately held companies in biologics, orthotics and prosthetics and sports medicine giving him a well-rounded perspective of the start-up environment.
MicroPort Orthopedics will benefit from Rob’s expertise as it continues to further itself as a leader in the medical device industry. In his new role, Rob will be leading the development and execution of global commercial strategy for 2022 and beyond, along with integrating commercial operations globally. Rob’s immediate priority will be running the US Sales and Marketing functions, with further expansion to global support in the near future.
“As a veteran in the medical device industry, I am looking forward to joining a company that values the innovation that is happening within this sector. MicroPort is rapidly expanding its footprint in the industry, and I am excited to be a part of its growth and strategy moving forward,” said Rob Cripe.
“Rob’s expertise will equip us with the tools necessary to continue our strategic growth, both in product development and technological advancements, in the US and beyond,” said Benny Hagag, President of MicroPort Orthopedics. “This valuable addition to our team is yet another way that MicroPort is prioritizing advancing in the orthopedic space and medical devices as a whole.